Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

M. Müller1

  • 1Abteilung für Klinische Pharmakokinetik, Universitätsklinik für Klinische Pharmakologie, Universität Wien.

Onkologie
|July 7, 2001
PubMed
Summary
This summary is machine-generated.

Clinical oncological drug studies face challenges in early detection and patient safety. This article reviews the traditional three-phase trial concept, noting recent advancements in Phase I and potential modifications for novel anticancer drugs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secundum atrial septal defects - a review of 75 patients.

Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners·2001
Same journal

Successful treatment with nab-paclitaxel and gemcitabine after FOLFIRINOX failure in a patient with metastasized pancreatic adenocarcinoma.

Onkologie·2013
Same journal

Metastatic germ cell tumour following renal transplantation.

Onkologie·2013
Same journal

miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc.

Onkologie·2013
Same journal

A meta-analysis of internal mammary lymph node metastasis in breast cancer patients.

Onkologie·2013
Same journal

Patient-related delay in presentation for cutaneous squamous cell carcinoma. A cross-sectional clinical study.

Onkologie·2013
Same journal

Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.

Onkologie·2013
See all related articles

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • Clinical oncological drug studies aim to identify effective cancer drug candidates early and minimize patient risk from ineffective treatments.
  • The traditional three-phase clinical trial model is the established framework for addressing these challenges in oncology drug development.

Purpose of the Study:

  • To provide a concise overview of the scientific logic underpinning the three phases of clinical oncological drug trials.
  • To discuss recent advancements and potential future modifications to the classical trial design.

Main Methods:

  • Review of the established three-phase clinical trial concept in oncology.
  • Analysis of recent progress, particularly in Phase I dose escalation procedures.
  • Discussion on the applicability of the classical model to novel anticancer agents.

Related Experiment Videos

Main Results:

  • Recent innovations in Phase I trials, such as novel dose escalation methods, have accelerated the phase and increased patient exposure to therapeutic drug concentrations.
  • The classical three-phase model may require critical reassessment for its suitability with certain novel anticancer drugs.

Conclusions:

  • The traditional three-phase clinical trial structure is fundamental to oncological drug development.
  • Adaptations to the classical model are anticipated to accommodate the unique characteristics of emerging anticancer therapies, ensuring continued progress in cancer treatment.